Please provide your email address to receive an email when new articles are posted on . The Alliance for Cancer Gene Therapy awarded $1.3 million worth of grants to fund three clinical trials that ...
The study, from investigators at the University of Alabama at Birmingham and Nationwide Children’s Hospital, builds on previous trials of G207. The current study further examined findings from an ...
The surprisingly positive treatment outcomes using Rigvir virotherapy for late stages cancer patients were recently published. The patients of melanoma stage IV M1c, small cell lung cancer stage IIIA ...
SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor ...
– Preclinical models have demonstrated the ability to resist oncolytic virus inactivation by human serum and target diverse tumor types – Novel therapeutic approach allows for ease of administration, ...
PHOENIX--(BUSINESS WIRE)--OncoMyx Therapeutics, a privately-held viral immunotherapy company, announced the presentation of preclinical data at the AACR Virtual Special Conference: Tumor Immunology ...
A phase 1/2 dose escalation and expansion study of sonodynamic therapy with SONALA-001 in combination with Exablate 4000 Type 2.0 MR-guided focused ultrasound in patients with progressive or recurrent ...
ATLANTA -- The experimental oncolytic adenovirus telomelysin (OBP-301) in combination with radiotherapy was safe and showed early clinical efficacy in vulnerable patients with esophageal cancer, ...
For Jennifer Amsley and daughter Xia Martinez of Maryland, an oncolytic virotherapy study at Children’s of Alabama has strengthened their resolve to fight and their desire for a sense of normalcy. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results